Heterologous hosts

US9580717B2 · kind B2 · utility

Assignee

• Gene Bridges GMBH · DE

Inventors

• Youming Zhang · Heidelberg, DE
• Jun Fu · Beijing, CN
• Xiaoying Bian · Heidelberg, DE
• Adrian Francis Stewart · Dresden, DE
• Rolf Müller · Heidelberg, DE

Key dates

• Filing date: Dec 17, 2010
• Grant date: Feb 28, 2017
• Expiry date: Feb 28, 2034

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02P20/52
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention is related to bacterial engineering and the heterologous expression of useful compounds. In particular, the invention relates to a heterologous host that has been engineered for expression of a gene which is capable of polyketide or non-ribosomal peptide synthesis. Methods of treating cancer are also disclosed.